CST BLOG: Lab Expectations

The official blog of Cell Signaling Technology (CST), where we discuss what to expect from your time at the bench, share tips, tricks, and information.

Webinar | Key Signaling Pathways in Cancer: Emerging Trends in Immunometabolism

Read More
All Posts
2016_11_emerging_trends_immuno_webinar_1600X800.jpg

Immune cells divide rapidly when mounting an immune response against a pathogen, for example, or when initiating a wound-healing response. To accommodate the increased energy requirements to mount the immune response, these cells may employ metabolic pathways similar to those engaged by cancer cells—pathways such as aerobic glycolysis. This correlation presents the intriguing possibility that understanding immune cell metabolism will provide new and actionable insights into the behavior of tumor cells. In this webinar, our expert speakers will explore how this phenomenon is being studied and describe how it could enable the development of new strategies in the fight against cancer. 

During the webinar, the speakers will:

  • Describe how aerobic glycolysis contributes to energy production in immune cells
  • Elucidate the role of lipid metabolism and mitochondrial remodeling in T-cell metabolism
  • Explain how metabolic changes impact the inflammation response and innate immunity

Featured Speakers:

Max Planck Institute of Immunobiology and Epigenetics
Freiburg, Germany

Trinity College Dublin
Dublin, Ireland

  Watch Now

You can also check out our Cellular Metabolism Resource page, dowload the CST Metabolism brochure, or view a related webinar on metabolism, autophagy, and identification of AMPK pathway substrates as potential cancer therapeutics.

Recent Posts

Cell Preparation Tips for Accurate Flow Cytometry Data

Generating accurate flow cytometry data requires more than just specific and sensitive antibodies validat...
Andrea Tu, PhD Nov 6, 2024

500 Antibodies & Counting: Accelerating Discovery with CST Antibodies Validated for Simple Western Technology

Since 2022, Cell Signaling Technology (CST) and Bio-Techne have been working together to bring best-in-cl...
Chris LaBreck, PhD Oct 23, 2024

Menin-KMT2A Inhibitors: A Promising Approach to Acute Myeloid Leukemia (AML) Treatment

Accounting for about 80% of adult acute leukemias, acute myeloid leukemia (AML) is an aggressive form of ...
Homa Rahnamoun, PhD Oct 16, 2024